Page last updated: 2024-10-21

pd 173074 and Colorectal Neoplasms

pd 173074 has been researched along with Colorectal Neoplasms in 2 studies

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Cholangiocarcinoma is an intractable cancer, with limited therapeutic options, in which the molecular mechanisms underlying tumor development remain poorly understood."1.40Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. ( Arai, Y; Furuta, K; Hama, N; Hosoda, F; Kosuge, T; Nakamura, H; Ojima, H; Okusaka, T; Shibata, T; Shimada, K; Shirota, T; Totoki, Y, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, Y1
Totoki, Y1
Hosoda, F1
Shirota, T1
Hama, N1
Nakamura, H1
Ojima, H1
Furuta, K1
Shimada, K1
Okusaka, T1
Kosuge, T1
Shibata, T1
Mathur, A1
Ware, C1
Davis, L1
Gazdar, A1
Pan, BS1
Lutterbach, B1

Other Studies

2 other studies available for pd 173074 and Colorectal Neoplasms

ArticleYear
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

    Topics: Adenosylhomocysteinase; Aged; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hep

2014
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Gene Amplificati

2014